Fernández-Cruz E, Alecsandru D, Rodríguez-Sainz C
Servicio de Inmunología Clínica, Hospital General Universitario Gregorio Marañón, Madrid, España.
Actas Dermosifiliogr. 2008 Jul;99 Suppl 4:2-6.
Biological therapies have revolutionized the treatment of chronic systemic diseases in which the immune system disorders form a part of the disease mechanism. In these diseases, the patients follow different drug treatments for long periods of time that causes serious adverse reactions and often obtain unsatisfactory efficacy results. Due to the research conducted in the last 10 years, biological drugs have been introduced into the treatment that are aimed against specific targets, such as inflammatory and immunopathological responses that give rise to tissue injury. The new biological therapies have improved the currently available treatments due to greater efficacy, fast action and greater tolerability. The present work aims to provide a global and up-dated view on the biological agents used most in the usual clinical practice and their importance in the management of the chronic immunologically based inflammatory diseases.
生物疗法彻底改变了慢性全身性疾病的治疗方式,在这些疾病中,免疫系统紊乱是疾病机制的一部分。在这些疾病中,患者长期接受不同的药物治疗,这会导致严重的不良反应,且疗效往往不尽人意。由于过去10年的研究,已将针对特定靶点的生物药物引入治疗,例如针对引起组织损伤的炎症和免疫病理反应。新的生物疗法因其更高的疗效、更快的起效速度和更好的耐受性,改进了现有的治疗方法。本研究旨在全面、更新地介绍在日常临床实践中最常用的生物制剂及其在慢性免疫性炎症疾病管理中的重要性。